Pharmas get huge impacts if being careless on ‘Financial Gain and Expenditure Report’

While the ‘Financial Gain and Expenditure Report’ will be implemented January next year, pharmaceutical companies were criticized to have thorough preparations.

This is because they might get in a huge trouble as judging the report don’t need to be turned in to the government as an obligation and punishment for violating this is weak.

According to Lawyer Jae-Joon Lim at the law firm Kim & Cha...